EP on EP Episode 91: Return to Sports (Part 1) with Michael J. Ackerman, MD, PhD-EP on EP Episode 91: Return to Sports (Part 1) with Michael J. Ackerman, MD, PhD

EP on EP Episode 91: Return to Sports (Part 1) with Michael J. Ackerman, MD, PhD

Video Transcription

Video Summary

In this segment of EP on EP, Dr. Michael Ackerman, a genetic cardiologist at the Mayo Clinic, discusses the concept of return to play in athletes with genetic heart conditions, specifically focusing on Long QT syndrome. Traditionally, athletes with this condition have been sidelined due to the perceived risk of sudden cardiac events. However, Dr. Ackerman argues that a better approach is needed and that shared decision making should be used to assess the individual risks and benefits for each athlete. He shares his experience of treating over 500 athletes with Long QT syndrome who have returned to play with minimal event rates. Dr. Ackerman also discusses the use of beta blockers as the primary therapy for most athletes with Long QT syndrome, as well as the alternative option of left cardiac sympathetic denervation surgery for those who cannot tolerate beta blockers. He also highlights the importance of preparing athletes and their families for the different decision-making models used at the professional and university levels. Overall, Dr. Ackerman emphasizes the need for individualized and informed decision making to allow athletes with genetic heart conditions to safely participate in sports.

Keywords

Long QT syndrome

return to play

shared decision making

beta blockers

genetic heart conditions